Silexion Therapeutics Corp. (SLXN)
0.36
-0.01
(-2.07%)
USD |
NASDAQ |
Aug 25, 16:00
0.3596
0.00 (0.00%)
After-Hours: 18:34
Silexion Therapeutics Net Income (Quarterly) : -3.551M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.551M |
| March 31, 2026 | -2.733M |
| December 31, 2025 | -4.412M |
| September 30, 2025 | -3.262M |
| June 30, 2025 | -2.503M |
| March 31, 2025 | -1.735M |
| December 31, 2024 | -1.747M |
| September 30, 2024 | -11.86M |
| June 30, 2024 | -1.489M |
| March 31, 2024 | -1.423M |
| December 31, 2023 | -1.68M |
| September 30, 2023 | 0.0741M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.1629M |
| March 31, 2023 | 0.3132M |
| December 31, 2022 | 0.4944M |
| September 30, 2022 | 0.2926M |
| June 30, 2022 | 0.0427M |
| March 31, 2022 | -0.2457M |
| December 31, 2021 | -0.2418M |
| September 30, 2021 | -0.2239M |
| June 30, 2021 | -0.1918M |
| March 31, 2021 | -0.0978M |
| December 31, 2020 | -0.1959M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioLineRx Ltd. | -2.581M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 9.262M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | -1.91M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.551M |
| EPS Diluted (Quarterly) | -5.166 |
| Enterprise Value | -0.4143M |
| Earnings Yield | -15.70K% |
| Normalized Earnings Yield | -15785.61 |